13D/13G Filings - AVORO CAPITAL ADVISORS LLC

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, 2, 3, 4, 5, Next
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2024-02-14
09:25 am
Purchase
2023-12-31 13G Krystal Biotech, Inc.
KRYS
AVORO CAPITAL ADVISORS LLC 2,565,555
9.100%
1,155,555increase
(+81.95%)
Filing
History
2024-02-14
09:23 am
Purchase
2023-12-31 13G Apellis Pharmaceuticals, Inc.
APLS
AVORO CAPITAL ADVISORS LLC 13,411,111
9.900%
2,786,111increase
(+26.22%)
Filing
History
2024-02-14
09:22 am
Purchase
2023-12-31 13G Amicus Therapeutics, Inc.
FOLD
AVORO CAPITAL ADVISORS LLC 27,400,000
9.300%
600,000increase
(+2.24%)
Filing
History
2024-02-14
09:21 am
Purchase
2023-12-31 13G Madrigal Pharmaceuticals, Inc.
MDGL
AVORO CAPITAL ADVISORS LLC 2,288,888
9.900%
628,888increase
(+37.88%)
Filing
History
2024-02-14
09:20 am
Sale
2023-12-31 13G Mersana Therapeutics, Inc.
MRSN
AVORO CAPITAL ADVISORS LLC 0
0.000%
-7,550,000decrease
(Position Closed)
Filing
History
2024-02-14
09:18 am
Sale
2023-12-31 13G PMV Pharmaceuticals, Inc.
PMVP
AVORO CAPITAL ADVISORS LLC 0
0.000%
-3,060,000decrease
(Position Closed)
Filing
History
2024-02-14
09:17 am
Purchase
2023-12-31 13G Ascendis Pharma A/S
ASND
AVORO CAPITAL ADVISORS LLC 3,755,555
6.500%
655,555increase
(+21.15%)
Filing
History
2024-02-14
09:15 am
Sale
2023-12-31 13G Kymera Therapeutics, Inc.
KYMR
AVORO CAPITAL ADVISORS LLC 3,775,000
6.800%
-75,000decrease
(-1.95%)
Filing
History
2024-02-14
09:14 am
Purchase
2023-12-31 13G Monte Rosa Therapeutics, Inc.
GLUE
AVORO CAPITAL ADVISORS LLC 4,535,000
9.100%
210,000increase
(+4.86%)
Filing
History
2024-02-14
09:13 am
Sale
2023-12-31 13G Mirati Therapeutics, Inc.
MRTX
AVORO CAPITAL ADVISORS LLC 4,886,840
7.000%
-668,715decrease
(-12.04%)
Filing
History
2024-02-14
09:12 am
Purchase
2023-12-31 13G Xenon Pharmaceuticals Inc.
XENE
AVORO CAPITAL ADVISORS LLC 5,666,666
7.700%
766,666increase
(+15.65%)
Filing
History
2024-02-14
09:10 am
Purchase
2023-12-31 13G Verrica Pharmaceuticals Inc.
VRCA
AVORO CAPITAL ADVISORS LLC 6,583,332
9.990%
6,583,332increase
(New Position)
Filing
History
2024-02-14
09:09 am
Purchase
2023-12-31 13G CymaBay Therapeutics, Inc.
CBAY
AVORO CAPITAL ADVISORS LLC 16,337,739
9.990%
3,537,739increase
(+27.64%)
Filing
History
2024-02-14
09:08 am
Purchase
2023-12-31 13G Spyre Therapeutics, Inc.
SYRE
AVORO CAPITAL ADVISORS LLC 2,125,597
5.900%
2,125,597increase
(New Position)
Filing
History
2024-02-14
09:07 am
Purchase
2023-12-31 13G Structure Therapeutics Inc.
GPCR
AVORO CAPITAL ADVISORS LLC 6,999,999
5.000%
6,999,999increase
(New Position)
Filing
History
2024-02-14
09:05 am
Sale
2023-12-31 13G United Therapeutics Corporation
UTHR
AVORO CAPITAL ADVISORS LLC 2,858,888
6.100%
-6,112decrease
(-0.21%)
Filing
History
2024-02-14
09:04 am
Unchanged
2023-12-31 13G Marinus Pharmaceuticals, Inc.
MRNS
AVORO CAPITAL ADVISORS LLC 3,150,000
5.800%
0
(Unchanged)
Filing
History
2024-02-14
09:02 am
Purchase
2023-12-31 13G BioCryst Pharmaceuticals, Inc.
BCRX
AVORO CAPITAL ADVISORS LLC 13,050,000
6.400%
13,050,000increase
(New Position)
Filing
History
2024-02-14
09:00 am
Sale
2023-12-31 13G IO Biotech, Inc.
IOBT
AVORO CAPITAL ADVISORS LLC 0
0.000%
-2,055,883decrease
(Position Closed)
Filing
History
2023-02-14
09:41 am
Sale
2022-12-31 13G Xenon Pharmaceuticals Inc.
XENE
AVORO CAPITAL ADVISORS LLC 4,900,000
7.800%
-85,000decrease
(-1.71%)
Filing
History
Goto Prev, 0, 1, 2, 3, 4, 5, Next